For more please check https://www.bocsci.com/holding....-hands-using-peptide
Like
Comment
Share
Nov
27
Dr Kelly's team synthesized a PDC series of PDCs designed to treat pulmonary fibrosis precisely, combining the kinase inhibitor nintedanib with a mimetic peptide chain targeting the αVβ6 integrin. Their antifibrotic activity is currently being evaluated in a mouse model of pulmonary fibrosis.
27-11-24 - 10:00 Start date
27-11-24 - 16:00 End date
New York, NY 11967
Load more posts